Illumina, Inc. (ILMN): Cost of Revenue
$1.47B
Year ended 2025-12-28
$1.51B
Trailing 12 months to 2026-06-28
-3.0%
3-year compound annual growth
+7.3%
5-year compound annual growth
+8.2%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $1.47B | -2.5% | 2026-02-12, From 2024-12-30 |
| 2024-12-29 | $1.51B | -14.1% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $1.76B | +9.2% | 2026-02-12, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | $1.61B | +17.5% | 2025-02-12, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $1.37B | +32.4% | 2024-02-16, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $1.04B | -3.7% | 2023-02-17, From 2019-12-30 |
| 2019-12-29 | $1.08B | +4.2% | 2022-02-18, From 2018-12-31 |
| 2018-12-30 | $1.03B | +11.6% | 2021-02-17, From 2018-01-01 |
| 2017-12-31 | $926.00M | +26.5% | 2020-02-11, From 2017-01-02 |
| 2017-01-01, Fiscal 2016 | $732.00M | +9.1% | 2019-02-12, From 2016-01-04 |
| 2016-01-03, Fiscal 2015 | $671.00M | +19.0% | 2018-02-13, From 2014-12-29 |
| 2014-12-28 | $563.65M | +10.7% | 2017-02-14, From 2013-12-30 |
| 2013-12-29 | $509.29M | +35.8% | 2016-03-02, From 2012-12-31 |
| 2012-12-30 | $374.99M | +8.2% | 2015-02-18, From 2012-01-02 |
| 2012-01-01, Fiscal 2011 | $346.44M | +15.0% | 2014-02-18, From 2011-01-03 |
| 2011-01-02, Fiscal 2010 | $301.20M | +41.8% | 2013-02-15, From 2010-01-04 |
| 2010-01-03, Fiscal 2009 | $212.45M | -3.5% | 2012-02-24, From 2008-12-29 |
| 2008-12-28 | $220.13M | n/a | 2011-02-28, From 2007-12-31 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Illumina, Inc. (ILMN) | 2025-12-28 | $1.47B | -2.5% |
| Bruker Corp (BRKR) | 2025-12-31 | $1.86B | +8.3% |
| Waters Corp (WAT) | 2025-12-31 | $1.29B | +7.4% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $4.41B | -2.0% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $3.31B | +11.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $1.24B | +4.7% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $198.94M | +1.3% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $97.03M | +8.6% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $114.22M | -2.1% |
Compare ILMN, BRKR, WAT, AVTR side by side · Screen every company in Laboratory Analytical Instruments ↗